Mass spectrometry should be utilized effectively to optimize biosimilar analysis, which can reduce development time and cost.
Mario DiPaola
Advertisement
Mario DiPaola is senior scientific director at Charles River Laboratories, Woburn, MA.
Articles by Mario DiPaola
Advertisement
Latest Updated Articles
Accelerating Biosimilar AnalysisPublished: October 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
